Catalyst Pharmaceuticals

-$0.05 (-0.75%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CPRX and other ETFs, options, and stocks.

About CPRX

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E.

CEO

Patrick J. McEnany

Employees

Headquarters

Coral Gables, Florida

Founded

2002

CPRX Key Statistics

Market cap

Price-Earnings ratio

15.97

Dividend yield

—

Average volume

1.46M

High today

$6.79

Low today

$6.43

Open price

$6.72

Volume

3.76M

52 Week high

$8.65

52 Week low

$4.81

CPRX News

Simply Wall StJun 25

What Type Of Shareholders Own The Most Number of Catalyst Pharmaceuticals, Inc. Shares?

Every investor in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of youn

CPRX Earnings

$0.00

$0.05

$0.09

$0.14

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 8, After Hours